Dow Up 0.07% Nasdaq Up 0.61%

Trevena, Inc. (TRVN)

-NasdaqGS
5.36 0.28(4.96%) Nov 26, 4:00PM EST
Prev Close:5.64
Open:5.59
Bid:0.01 x 100
Ask:7.67 x 100
1y Target Est:15.33
Beta:N/A
Next Earnings Date:N/A
Day's Range:5.10 - 5.54
52wk Range:4.01 - 9.95
Volume:65,015
Avg Vol (3m):52,766
Market Cap:141.38M
P/E (ttm):N/A
EPS (ttm):-2.48
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for TRVN

Comparison

Symbol% ChgMkt Cap
TRVNDown 4.96%141.38M
CYTK168.03M
NVS231.13B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-2.17
Quarterly EPS Est (Dec-14) :-0.56
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Trevena, Inc., a clinical stage biopharmaceutical company, discovers, develops, and intends to commercialize therapeutics for G protein coupled receptors. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback